| Ident. | Authors (with country if any) | Title |
|---|
| 000011 (2020) |
Charlotte Borocco [France] ; Claire Ballot-Schmit [France] ; Oanez Ackermann [France] ; Nathalie Aladjidi [France] ; Jeremie Delaleu [France] ; Vannina Giacobbi-Milet [France] ; Sarah Jannier [France] ; Eric Jeziorski [France] ; François Maurier [France] ; Yves Perel [France] ; Christophe Piguet [France] ; Eric Oksenhendler [France] ; Isabelle Koné-Paut [France] ; Caroline Galeotti [France] | The French paediatric cohort of Castleman disease: a retrospective report of 23 patients |
| 000012 (2020) |
Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France] | Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study |
| 000013 (2020) |
Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis] | Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes |
| 000023 (2020) |
Hermine I. Brunner [États-Unis] ; Nikolay Tzaribachev [Allemagne] ; Gabriel Vega Cornejo ; Rik Joos [Belgique] ; Elisabeth Gervais [France] ; Rolando Cimaz [Italie] ; Inmaculada Calvo Penadés [Espagne] ; Rubén Cuttica [Argentine] ; Thomas Lutz [Allemagne] ; Pierre Quartier [France] ; Yash Gandhi [États-Unis] ; Marleen Nys [Belgique] ; Robert Wong [États-Unis] ; Alberto Martini [Italie] ; Daniel J. Lovell [États-Unis] ; Nicolino Ruperto [Italie] | Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept |
| 000033 (2020) |
Jacqueline M. Tarrant [États-Unis] ; René Galien [France] ; Wanying Li [États-Unis] ; Lovely Goyal [États-Unis] ; Yang Pan [États-Unis] ; Rachael Hawtin [États-Unis] ; Wangshu Zhang [États-Unis] ; Annegret Van Der Aa [Belgique] ; Peter C. Taylor [Royaume-Uni] | Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials |
| 000056 (2019) |
Kevin L. Winthrop [États-Unis] ; Michael E. Weinblatt [États-Unis] ; Joan Bathon [États-Unis] ; Gerd R. Burmester [Allemagne] ; Philip J. Mease [États-Unis] ; Leslie Crofford [États-Unis] ; Vivian Bykerk [États-Unis] ; Maxime Dougados [France] ; James Todd Rosenbaum [États-Unis] ; Xavier Mariette [France] ; Joachim Sieper [Allemagne] ; Fritz Melchers [Allemagne] ; Bruce N. Cronstein [États-Unis] ; Ferry C. Breedveld [Pays-Bas] ; Joachim Kalden [Allemagne] ; Josef S. Smolen [Autriche] ; Daniel Furst [États-Unis, Italie] | Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019 |
| 000057 (2019) |
Christoph Lohan [Royaume-Uni] ; Alex Diamantopoulos [Royaume-Uni] ; Corinne Lereun [France] ; Emily Wright [Royaume-Uni] ; Natalie Bohm [Royaume-Uni] ; Laura Marie Sawyer [Royaume-Uni] | Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation |
| 000059 (2019) |
Jean Darloy [France] ; Nicolas Segaud [France] ; Jean-Hugues Salmon [France] ; Jean-Paul Eschard [France] ; Vincent Goëb [France] ; Xavier Deprez [France] ; Marie-Hélène Guyot [France] ; Eric Houvenagel [France] ; Nicolas Lecuyer [France] ; Laurent Marguerie [France] ; Samuel Gally [France] ; David Pau [France] ; Isabelle Idier [France] ; Guy Baudens [France] ; René-Marc Flipo [France] | Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study |
| 000060 (2019) |
Marine Ibranosyan [France] ; Laetitia Beraud [France] ; Hélène Lemaire [France] ; Anne-Gaëlle Ranc [France] ; Christophe Ginevra [France] ; Sophie Jarraud [France] ; Ghislaine Descours [France] | The clinical presentation of Legionella arthritis reveals the mode of infection and the bacterial species: case report and literature review |
| 000064 (2019) |
Sara Monti [Italie] ; Ana F. Águeda [Portugal] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne] | Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis |
| 000072 (2019) |
Olivier Vittecoq [France] ; Sandra Desouches [France] ; Marie Kozyreff [France] ; Julia Nicolau [France] ; Sophie Pouplin [France] ; Pascal Rottenberg [France] ; Nicolas Sens [France] ; Thierry Lequerre [France] ; Gilles Avenel [France] | Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study |
| 000074 (2019) |
Mike Becker [Suisse] ; Nicole Graf [Suisse] ; Rafael Sauter [Royaume-Uni] ; Yannick Allanore [France] ; John Curram [Royaume-Uni] ; Christopher P. Denton [Royaume-Uni] ; Dinesh Khanna [États-Unis] ; Marco Matucci-Cerinic [Italie] ; Janethe De Oliveira Pena [États-Unis] ; Janet E. Pope [Canada] ; Oliver Distler [Suisse] | Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis |
| 000075 (2019) |
Cassandra Calabrese [États-Unis] ; Laura C. Cappelli [États-Unis] ; Marie Kostine [France] ; Elizabeth Kirchner [États-Unis] ; Tawnie Braaten [États-Unis] ; Leonard Calabrese [États-Unis] | Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature |
| 000080 (2019) |
Frederike C. Oertel [Allemagne] ; Olivier Outteryck [France] ; Benjamin Knier [Allemagne] ; Hanna Zimmermann [Allemagne] ; Nadja Borisow [Allemagne] ; Judith Bellmann-Strobl [Allemagne] ; Astrid Blaschek [Allemagne] ; Sven Jarius [Allemagne] ; Markus Reindl [Autriche] ; Klemens Ruprecht [Allemagne] ; Edgar Meinl [Allemagne] ; Reinhard Hohlfeld [Allemagne] ; Friedemann Paul [Allemagne] ; Alexander U. Brandt [Allemagne, États-Unis] ; Tania Kümpfel [Allemagne] ; Joachim Havla [Allemagne] | Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study |
| 000089 (2019) |
Ana F. Águeda [Portugal] ; Sara Monti [Italie] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne] | Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis |
| 000090 (2019) |
Jeffrey R. Curtis [États-Unis] ; Xavier Mariette [France] ; Cécile Gaujoux-Viala [France] ; Andrew Blauvelt [États-Unis] ; Tore K. Kvien [Norvège] ; William J. Sandborn [États-Unis] ; Kevin Winthrop [États-Unis] ; Marc De Longueville [Belgique] ; Ivo Huybrechts [Belgique] ; Vivian P. Bykerk [États-Unis] | Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials |
| 000095 (2019) |
Vincent Cottin [France] ; Kevin K. Brown [États-Unis] | Interstitial lung disease associated with systemic sclerosis (SSc-ILD) |
| 000097 (2019) |
Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France] | Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs |
| 000098 (2019) |
Yann Nguyen [France] ; Carine Salliot [France] ; Gaëlle Gusto [France] ; Elise Descamps [France] ; Xavier Mariette [France] ; Marie-Christine Boutron-Ruault [France] ; Raphaèle Seror [France] | Improving accuracy of self-reported diagnoses of rheumatoid arthritis in the French prospective E3N-EPIC cohort: a validation study |
| 000103 (2019) |
Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France] | Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses |
| 000104 (2019) |
Ivan Foeldvari [Allemagne] ; Tamàs Constantin [Hongrie] ; Jelena Vojinovi [Serbie] ; Gerd Horneff [Allemagne] ; Vyacheslav Chasnyk [Russie] ; Joke Dehoorne [Belgique] ; Violeta Panaviene [Lituanie] ; Gordana Suši [Serbie] ; Valda Stanevicha [Lettonie] ; Katarzyna Kobusinska [Pologne] ; Zbigniew Zuber [Pologne] ; Bogna Dobrzyniecka [Pologne] ; Irina Nikishina [Russie] ; Brigitte Bader-Meunier [France] ; Luciana Breda [Italie] ; Pavla Doležalová [République tchèque] ; Chantal Job-Deslandre [France] ; Ingrida Rumba-Rozenfelde [Lettonie] ; Nico Wulffraat [Pays-Bas] ; Ronald D. Pedersen [États-Unis] ; Jack F. Bukowski [États-Unis] ; Bonnie Vlahos [États-Unis] ; Alberto Martini [Italie] ; Nicolino Ruperto [Italie] | Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial |
